Action Prenetics Global - PRE

Prenetics Global Ltd (PRE) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

19,31

( -2,08% )

Prix Achat

19,30

Prix Vente

20,49

Volume échangé

1 705

0,00 Fourchette du Jour 0,00

7,175 Plage de 52 semaines 23,63

Cap du marché

324,957M

Clôture Veille

19,72

Ouverture

Dernière Transaction

1500

19.31

(formt)

Dernière heure de transaction

13:15:14

Volume financier

VWAP

Volume moyen (3 m)

US$ 216 431

Actions en circulation

16 828 437

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-5,37

Bénéfice par action (BPA)

-3,33

Chiffre d'affairess (LTM)

120,07M

Bénéfice net (LTM)

-50,42M

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging seque... Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong. Show more

Secteur

Healthcare

Industrie

Medical Diagnostics & Screening

Site Web

www.prenetics.com

Siège social

Quarry Bay, Hong Kong

Fondé

2026

Prenetics Global Ltd est coté dans le secteur Healthcare de la NASDAQ avec le ticker PRE. Le dernier cours de clôture d'Prenetics Global était de US$19,72. Au cours de la dernière année, les actions de Prenetics Global ont été négociées dans une fourchette de prix de US$ 7,175 à US$ 23,63.

Prenetics Global compte actuellement 16 828 437 actions en circulation. La capitalisation boursière d'Prenetics Global est de US$324,96 million. Prenetics Global a un ratio cours/bénéfice (ratio PE) de -5.37.

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million...

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Hudson Leogrande is the Founder and CEO of Comfrt — a multi-billion-dollar DTC brand projected to exceed $1...

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210...

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support...

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue...

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the...

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or...

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most...

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the...

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.63	-3.15947843531	19.94	20.815	19.21	130032	20.04699579	CS
4	2.06	11.9420289855	17.25	22.22	16.88	247743	20.48448965	CS
12	-0.16	-0.821777092964	19.47	22.22	14	218509	18.42272041	CS
26	2.17	12.6604434072	17.14	23.63	14	234698	18.47969616	CS
52	11.11	135.487804878	8.2	23.63	7.175	172008	16.62106365	CS
156	18.35	1911.45833333	0.96	23.63	0.2865	91742	11.7434791	CS
260	10.91	129.880952381	8.4	23.63	0.2865	142769	6.65765927	CS

PRE - Frequently Asked Questions (FAQ)

What is the current Prenetics Global Ltd share price?

The current share price of Prenetics Global Ltd is US$ 19,31

How many Prenetics Global Ltd shares are in issue?

Prenetics Global Ltd has 16 828 437 shares in issue

What is the market cap of Prenetics Global Ltd?

The market capitalisation of Prenetics Global Ltd is USD 324,96M

What is the 1 year trading range for Prenetics Global Ltd share price?

Prenetics Global Ltd has traded in the range of US$ 7,175 to US$ 23,63 during the past year

What is the PE ratio of Prenetics Global Ltd?

The price to earnings ratio of Prenetics Global Ltd is -5,37

What is the cash to sales ratio of Prenetics Global Ltd?

The cash to sales ratio of Prenetics Global Ltd is 2,79

What is the registered address of Prenetics Global Ltd?

The registered address for Prenetics Global Ltd is Unit 703-706, K11 Atelier King’s Road, Quarry Bay

What is the Prenetics Global Ltd website address?

The website address for Prenetics Global Ltd is www.prenetics.com

Which industry sector does Prenetics Global Ltd operate in?

Prenetics Global Ltd operates in the Medical Diagnostics & Screening sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Prenetics Global Ltd (PRE)

Prenetics Global Ltd (PRE) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Prenetics Global Ltd

PRE Dernières nouvelles

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

PRE - Frequently Asked Questions (FAQ)

PRE Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités